Skip to main content
PMC home page
Journal of Bacteriology logoLink to Journal of Bacteriology
. 1997 Aug;179(15):4789–4794. doi: 10.1128/jb.179.15.4789-4794.1997

Cloning and expression in Escherichia coli of genetic determinants for production of and immunity to microcin E492 from Klebsiella pneumoniae.

M Wilkens 1, J E Villanueva 1, J Cofré 1, J Chnaiderman 1, R Lagos 1
PMCID: PMC179325  PMID: 9244266

Abstract

Microcin E492 is a polypeptide antibiotic that is produced and excreted by Klebsiella pneumoniae RYC492. The genetic determinants for microcin synthesis and immunity were cloned in Escherichia coli VCS257 into the cosmid vector pHC79, starting from total DNA of K. pneumoniae RYC492. The microcin E492 expressed in E. coli had the same properties as that of K. pneumoniae, i.e., the same molecular weight, the ability to form ionic channels in planar phospholipid bilayers, and essentially identical biological properties. Microcin E492 expression in E. coli, like that in K. pneumoniae, was mainly in the exponential phase of growth, declining in the stationary phase. The immunity determinant was subcloned into the same vector, and its expression was found to disappear in the stationary phase. This phenomenon is not dependent on rpoS, the stationary-phase sigma factor.

Full Text

The Full Text of this article is available as a PDF (305.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abee T. Pore-forming bacteriocins of gram-positive bacteria and self-protection mechanisms of producer organisms. FEMS Microbiol Lett. 1995 Jun 1;129(1):1–10. doi: 10.1016/0378-1097(95)00137-T. [DOI] [PubMed] [Google Scholar]
  2. Bohannon D. E., Connell N., Keener J., Tormo A., Espinosa-Urgel M., Zambrano M. M., Kolter R. Stationary-phase-inducible "gearbox" promoters: differential effects of katF mutations and role of sigma 70. J Bacteriol. 1991 Jul;173(14):4482–4492. doi: 10.1128/jb.173.14.4482-4492.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cramer W. A., Heymann J. B., Schendel S. L., Deriy B. N., Cohen F. S., Elkins P. A., Stauffacher C. V. Structure-function of the channel-forming colicins. Annu Rev Biophys Biomol Struct. 1995;24:611–641. doi: 10.1146/annurev.bb.24.060195.003143. [DOI] [PubMed] [Google Scholar]
  4. Gaggero C., Moreno F., Laviña M. Genetic analysis of microcin H47 antibiotic system. J Bacteriol. 1993 Sep;175(17):5420–5427. doi: 10.1128/jb.175.17.5420-5427.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Guarente L. P., Beckwith J. Mutant RNA polymerase of Escherichia coli terminates transcription in strains making defective rho factor. Proc Natl Acad Sci U S A. 1978 Jan;75(1):294–297. doi: 10.1073/pnas.75.1.294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kolter R., Moreno F. Genetics of ribosomally synthesized peptide antibiotics. Annu Rev Microbiol. 1992;46:141–163. doi: 10.1146/annurev.mi.46.100192.001041. [DOI] [PubMed] [Google Scholar]
  7. Lagos R., Wilkens M., Vergara C., Cecchi X., Monasterio O. Microcin E492 forms ion channels in phospholipid bilayer membrane. FEBS Lett. 1993 Apr 26;321(2-3):145–148. doi: 10.1016/0014-5793(93)80096-d. [DOI] [PubMed] [Google Scholar]
  8. Mulvey M. R., Switala J., Borys A., Loewen P. C. Regulation of transcription of katE and katF in Escherichia coli. J Bacteriol. 1990 Dec;172(12):6713–6720. doi: 10.1128/jb.172.12.6713-6720.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Orellana C., Lagos R. The activity of microcin E492 from Klebsiella pneumoniae is regulated by a microcin antagonist. FEMS Microbiol Lett. 1996 Mar 1;136(3):297–303. doi: 10.1111/j.1574-6968.1996.tb08064.x. [DOI] [PubMed] [Google Scholar]
  10. Ortiz M., Lagos R., Monasterio O. Interaction between the C-terminal peptides of tubulin and tubulin S detected with the fluorescent probe 4',6-diamidino-2-phenylindole. Arch Biochem Biophys. 1993 May 15;303(1):159–164. doi: 10.1006/abbi.1993.1267. [DOI] [PubMed] [Google Scholar]
  11. Pugsley A. P., Moreno F., de Lorenzo V. Microcin-E492-insensitive mutants of Escherichia coli K12. J Gen Microbiol. 1986 Dec;132(12):3253–3259. doi: 10.1099/00221287-132-12-3253. [DOI] [PubMed] [Google Scholar]
  12. Schägger H., von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem. 1987 Nov 1;166(2):368–379. doi: 10.1016/0003-2697(87)90587-2. [DOI] [PubMed] [Google Scholar]
  13. Studier F. W., Moffatt B. A. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol. 1986 May 5;189(1):113–130. doi: 10.1016/0022-2836(86)90385-2. [DOI] [PubMed] [Google Scholar]
  14. Venema K., Venema G., Kok J. Lactococcal bacteriocins: mode of action and immunity. Trends Microbiol. 1995 Aug;3(8):299–304. doi: 10.1016/s0966-842x(00)88958-1. [DOI] [PubMed] [Google Scholar]
  15. Yang C. C., Konisky J. Colicin V-treated Escherichia coli does not generate membrane potential. J Bacteriol. 1984 May;158(2):757–759. doi: 10.1128/jb.158.2.757-759.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. de Lorenzo V. Factors affecting microcin E492 production. J Antibiot (Tokyo) 1985 Mar;38(3):340–345. doi: 10.7164/antibiotics.38.340. [DOI] [PubMed] [Google Scholar]
  17. de Lorenzo V. Isolation and characterization of microcin E492 from Klebsiella pneumoniae. Arch Microbiol. 1984 Sep;139(1):72–75. doi: 10.1007/BF00692715. [DOI] [PubMed] [Google Scholar]
  18. de Lorenzo V., Martínez J. L., Asensio C. Microcin-mediated interactions between Klebsiella pneumoniae and Escherichia coli strains. J Gen Microbiol. 1984 Feb;130(2):391–400. doi: 10.1099/00221287-130-2-391. [DOI] [PubMed] [Google Scholar]
  19. de Lorenzo V., Pugsley A. P. Microcin E492, a low-molecular-weight peptide antibiotic which causes depolarization of the Escherichia coli cytoplasmic membrane. Antimicrob Agents Chemother. 1985 Apr;27(4):666–669. doi: 10.1128/aac.27.4.666. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES